Enzymotec Ltd. (ENZY) Return on Investment ROI from the fourth quarter of 2016 to fourth quarter of 2015 and for the year 2016, average high and low, overall ranking from Dec 31 2016 to Dec 31 2015 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Enzymotec Ltd.  (ENZY)


Enzymotec Ltd.'s ROI from its fourth quarter of 2016 to the fourth quarter of 2015 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Enzymotec Ltd.'s ROI in the fourth quarter of 2016?
Enzymotec Ltd. recorded a cumulative net loss of $-3 million during 12 months ending in the fourth quarter of 2016, resulting in a negative return on investment (ROI) of -2.12%.

Within the Healthcare sector 184 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2016 from 0 to 2846.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2016)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2015)
IV. Quarter
Y / Y Investment Change TTM 0.04 % 1.6 % 36.17 % 106.41 % 326.42 %
Y / Y Net Income Change TTM - -14.74 % -14.74 % -14.74 % -14.74 %
Investment (TTM) in Millions 138 138 138 138 138
Return On Investment (TTM) -2.12 % 4.84 % 4.84 % 4.84 % 4.84 %
ENZY's Overall Ranking # 2846 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 0.01 % 0.01 % 0.01 % 0.01 % 1.57 %
Seq. Net Income Change TTM - 0 % 0 % 0 % -14.74 %
Net Income (TTM) in Millions -3 7 7 7 7

ENZY Company Profile >> Back to ENZY Roi Comparisons >> See Annual ENZY Return On Investment



Return On Investment ENZY's Ranking
Within: No.
Industry # 12
Sector # 185
Overall # 2846

Return On Investment Statistics
High Average Low
4.84 %
1.36 %
-2.12 %
  (Dec 31 2016)







Financial Statements
Enzymotec Ltd.'s IV. Quarter Investments $ 138 Millions ENZY's Balance sheet
Enzymotec Ltd.'s IV. Quarter Income $ -3 Millions Quarterly ENZY's Income Statement
ENZY's Income by Division See ENZY's Income by Division


ENZY Annual Return On Investment (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014		 (Dec 31 2011)
2013
Total Investments in Millions 138 138 129 124 0
Y / Y Investment Growth 0.04 % 6.6 % 4.73 % - -
Net Income in Millions -3 7 8 -1 0
Y / Y Net Income Growth - -14.74 % - - -
Annual Return On Investment -2.12 % 4.84 % 6.06 % -0.7 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ENZY's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ENZY's Competitors
Subscribers only: Roi for Enzymotec Ltd.'s Suppliers
Subscribers only: Return On Investment for ENZY's Customers

Other Ratios
ENZY's Roa ENZY's Inventory Turnover Ratio ENZY's Growth Rates ENZY's Dividend Statistics
ENZY's Profitability Ratios ENZY's Asset Turnover Ratio ENZY's Dividend Growth
ENZY's Roe ENZY's Valuation Ratios ENZY's Financial Strength Ratios ENZY's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2016, within Healthcare Sector ROI

Date modified: 2026-09-02T18:56:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.